A 52-year-old Indian man with Type 2 diabetes mellitus of 15 years' duration undergoes pancreatic biopsy. Which histopathological feature would most reliably distinguish his pancreatic pathology from that of a newly diagnosed Type 1 diabetic patient?

Question

Accepted Answer

A. Extensive islet amyloid deposition with preserved beta-cell architecture. ## Pathological Distinction: Long-Standing Type 2 vs. Type 1 DM

### Islet Amyloid Polypeptide (IAPP) Deposition: Signature of Type 2 DM

**Key Point:** Islet amyloid deposition is a hallmark of Type 2 DM, present in ~90% of Type 2 diabetics at autopsy, but rare in Type 1 DM. The amyloid is composed of islet amyloid polypeptide (IAPP/amylin), a hormone co-secreted with insulin by beta cells.

**High-Yield:** IAPP amyloid deposition distinguishes Type 2 DM from Type 1 DM. In Type 2, amyloid accumulates over years and may contribute to beta-cell dysfunction and death. This feature is essentially absent in Type 1 DM.

### Comparative Pathology in Long-Standing Disease

| Feature | Type 2 DM (15 years) | Type 1 DM (at diagnosis) |
|---------|----------------------|-------------------------|
| **Islet amyloid** | Extensive (90%+) | Absent/rare (<5%) |
| **Insulitis** | Absent | Present (CD8+ infiltrate) |
| **Beta-cell loss** | Gradual, 20–50% | Rapid, >90% |
| **Islet architecture** | Preserved initially, then disrupted | Disrupted early by inflammation |
| **Fibrosis** | Progressive | Minimal at onset |

### Why IAPP Amyloid Distinguishes Type 2

1. **Pathognomonic for Type 2**: IAPP amyloid deposition is a defining feature of Type 2 DM, reflecting chronic hyperinsulinemia and beta-cell stress. It is virtually absent in Type 1 DM.
2. **Preserved architecture**: In Type 2 DM, amyloid deposits within islets while the overall islet structure is initially preserved (unlike the inflammatory destruction in Type 1).
3. **Temporal pattern**: Amyloid accumulates progressively over years in Type 2 DM, whereas Type 1 DM shows acute autoimmune destruction at onset.

**Clinical Pearl:** IAPP amyloid may itself be toxic to beta cells, contributing to progressive beta-cell loss in Type 2 DM. This represents a distinct pathogenic mechanism from the autoimmune destruction in Type 1 DM.

**Mnemonic:** **IAPP in Type 2** — **I**slet **A**myloid **P**olypeptide is the **P**athologic hallmark of Type 2.

[cite:Robbins 10e Ch 24]

Answer

B. Complete absence of insulin-containing cells with fibrosis

Answer

C. Selective loss of alpha cells with preserved beta-cell mass

Answer

D. Diffuse insulitis with CD8+ T-cell infiltration and beta-cell loss

A 52-year-old Indian man with Type 2 diabetes mellitus of 15 years' duration undergoes pancreatic biopsy. Which histopathological feature would most reliably distinguish his pancreatic pathology from that of a newly diagnosed Type 1 diabetic patient?

Explanation

Practice similar questions